| Old Articles: <Older 4441-4446 |
 |
Pharmaceutical Executive March 1, 2013 |
China and the Emerging Markets Challenge: Why Big Pharma Must Embrace a New Strategy With health reform already tagged as a key domestic priority, their policies will pose new opportunities and challenges for Big Pharma companies active in China.  |
Pharmaceutical Executive March 1, 2013 |
Country Report: China China's pharmaceutical industry is making record gains. Four years ago, China was the world's fifth largest market. Now, it has bypassed France and Germany to become the third largest.  |
Pharmaceutical Executive February 1, 2013 |
Country Report: Australia In some ways the Australian medicines industry is going through the same restructuring and challenges as the industry is globally.  |
IEEE Spectrum January 2013 John Boyd |
Japan's Digital Grid Scheme Japanese consortium aims to transform the country's centralized grid into islands of interconnected cells  |
On Wall Street December 1, 2012 |
Five Questions with Schroders' Virginie Maisonneuve The head of Global and International Equities at Schroders discusses the global economy and why China's new leadership could be great for investors, and which nations could be troublesome.  |
Chemistry World November 28, 2012 Andrew Turley |
GSK expands in India and Nigeria GlaxoSmithKline is to spend 650 million pounds dramatically increasing its ownership of Indian and Nigerian subsidiaries.  |
| <Older 4441-4446 Return to current articles. |